Author:
Liu Houjun,Weakley Alyssa M.,Zhang Jiawei,Liu Xin
Publisher
Springer Nature Switzerland
Reference12 articles.
1. Gauthier, S. Advances in the pharmacotherapy of Alzheimer’s disease. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne 166. Place: Canada, 616–623. ISSN: 0820-3946 1488-2329 (Mar. 5, 2002).
2. Martínez-Florez, J. F. et al. Short-Term Memory Binding Distinguishing Amnes-tic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study. Journal of Alzheimer’s Disease 81. Publisher: IOS Press, 729–742. ISSN: 1875-8908 (2021).
3. Nowrangi, M. A., Rosenberg, P. B. & Leoutsakos, J.-M. S. Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database. International Psychogeriatrics 28, 2009-2018. ISSN: 1041-6102, 1741-203X. https://www.cambridge.org/core/product/identifier/S1041610216000995/type/journal_ article (Dec. 2016).
4. Davatzikos, C., Bhatt, P., Shaw, L. M., Batmanghelich, K. N. & Trojanowski, J. Q. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology of Aging 32, 2322.e19–2322.e27. ISSN: 01974580. https://linkinghub.elsevier.com/retrieve/pii/S019745801000237X (Dec. 2011).
5. Evci, U., Pedregosa, F., Gomez, A. & Elsen, E. The Difficulty of Training Sparse Neural Networks Oct. 7, 2020. http://arxiv.org/abs/1906.10732.